Drug:
Reaction: MATERNAL EXPOSURE DURING PREGNANCY
20250101 - 20251231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 25127568 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 102 | 25127581 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 103 | 25127658 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 104 | 25127676 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 105 | 25127699 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 106 | 25127704 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 107 | 25127741 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 108 | 25127796 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 109 | 25127802 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 110 | 25127818 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 111 | 25127823 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 112 | 25127828 |
DE |
40 | 2 |
Abortion, Maternal exposure during pregnancy, |
||||
UPADACITINIB, UPADACITINIB, |
||||
| 113 | 25127837 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 114 | 25127852 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 115 | 25127867 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 116 | 25128204 |
US |
51 | 2 |
Systemic lupus erythematosus, Autoimmune pancreatitis, Type 1 diabetes mellitus, Retinopathy, Gastrointestinal haemorrhage, Episcleritis, JC polyomavirus test positive, Maternal exposure during pregnancy, |
||||
PREDNISONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, |
||||
| 117 | 25128240 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 118 | 25128261 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 119 | 25128297 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 120 | 25128324 |
FR |
28 | 2 |
Hypotension, Somnolence, Paraesthesia, Maternal exposure during pregnancy, |
||||
LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, ROPIVACAINE HYDROCHLORIDE, SUFENTANIL, |
||||
| 121 | 25128357 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, Pre-eclampsia, Gestational hypertension, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 122 | 25128365 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, Pre-eclampsia, Gestational hypertension, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 123 | 25128370 |
US |
33 | 2 |
Treatment failure, Maternal exposure during pregnancy, Off label use, |
||||
LABETALOL, DIGOXIN, |
||||
| 124 | 25128666 |
FR |
2 | |
B-cell aplasia, Maternal exposure during pregnancy, |
||||
DOXORUBICIN, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, VINCRISTINE SULFATE, |
||||
| 125 | 25128703 |
US |
33 | 2 |
Maternal exposure during pregnancy, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 126 | 25128706 |
US |
37 | 2 |
Injection site swelling, Maternal exposure during pregnancy, |
||||
DUPILUMAB, |
||||
| 127 | 25128744 |
US |
36 | 2 |
Maternal exposure during pregnancy, |
||||
DUPILUMAB, |
||||
| 128 | 25128811 |
US |
31 | 2 |
Maternal exposure during pregnancy, |
||||
DUPILUMAB, |
||||
| 129 | 25129165 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 130 | 25129196 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 131 | 25129299 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 132 | 25129437 |
NL |
28 | 2 |
Pregnancy with implant contraceptive, Maternal exposure during pregnancy, |
||||
ETONOGESTREL, |
||||
| 133 | 25129440 |
FR |
37 | 2 |
Hypotension, Somnolence, Paraesthesia, Maternal exposure during pregnancy, |
||||
LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, ROPIVACAINE HYDROCHLORIDE, SUFENTANIL, |
||||
| 134 | 25129548 |
CA |
44 | 2 |
Delirium, Wound, Weight decreased, Dry mouth, Diarrhoea, X-ray abnormal, Exposure during pregnancy, Joint swelling, Contusion, Confusional state, Laboratory test abnormal, Weight fluctuation, Wheezing, Wound infection, Colitis ulcerative, Crohn^s disease, Discomfort, White blood cell count increased, Maternal exposure during pregnancy, Depression, Weight increased, |
||||
IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, LORAZEPAM, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, AZATHIOPRINE, CAFFEINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, PREGABALIN, ALBUTEROL SULFATE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, INFLIXIMAB, RAMIPRIL, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, MAGNESIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, FLUOROMETHOLONE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, HYALURONIDASE, MORPHINE, RITUXIMAB, RITUXIMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LISINOPRIL, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, CALCIUM CARBONATE, MESALAMINE, APREPITANT, FOSAPREPITANT DIMEGLUMINE, ERGOCALCIFEROL, USTEKINUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, CAFFEINE CITRATE, LEFLUNOMIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, LANSOPRAZOLE, LORAZEPAM, SULFASALAZINE, SULFASALAZINE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, TOFACITINIB, ACETAMINOPHEN AND DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN AND PHENYLEPRINE HCL, ACETAMINOPHEN AND DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN AND PHENYLEPRINE HCL, DOXYCYCLINE, DOXYCYCLINE HYCLATE, VITAMIN C, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, APREMILAST, APREMILAST, APREMILAST, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ERYTHROMYCIN, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, PREDNISONE, PREDNISONE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, LISINOPRIL, ALBUTEROL SULFATE, ALBUTEROL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, MELOXICAM, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, |
||||
| 135 | 25129624 |
US |
||
Dermatitis, Dermatitis, Maternal exposure during pregnancy, |
||||
SCOLOPAMINE TRANSDERMAL SYSTEM, |
||||
| 136 | 25129650 |
FR |
2 | |
B-cell aplasia, Maternal exposure during pregnancy, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, PREDNISOLONE ACETATE, RITUXIMAB, VINCRISTINE SULFATE, |
||||
| 137 | 25129656 |
US |
1 | 2 |
Maternal exposure during pregnancy, Blood glucose decreased, Foetal distress syndrome, Small for dates baby, |
||||
RIMEGEPANT SULFATE, |
||||
| 138 | 25129743 |
FR |
36 | 2 |
Reversible cerebral vasoconstriction syndrome, Hypertension, Posterior reversible encephalopathy syndrome, Maternal exposure during pregnancy, Off label use, |
||||
METHYLPREDNISOLONE SODIUM SUCCINATE, |
||||
| 139 | 25129865 |
US |
2 | |
Maternal exposure before pregnancy, Maternal exposure during pregnancy, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 140 | 25129943 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 141 | 25129950 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 142 | 25129956 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 143 | 25129982 |
BR |
34 | 2 |
Abortion early, Maternal exposure during pregnancy, Pain, |
||||
DIMETHYL FUMARATE, DIMETHYL FUMARATE, |
||||
| 144 | 25129988 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 145 | 25130004 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 146 | 25130011 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 147 | 25130020 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 148 | 25130028 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 149 | 25130077 |
FR |
0 | |
Maternal exposure during pregnancy, Maternal exposure during pregnancy, Premature baby, Low birth weight baby, |
||||
DAPAGLIFLOZIN, APIXABAN, FUROSEMIDE, SPIRONOLACTONE, SACUBITRIL AND VALSARTAN, ENOXAPARIN SODIUM, BISOPROLOL FUMARATE, ENOXAPARIN SODIUM, |
||||
| 150 | 25130217 |
CA |
65 | 2 |
Adjustment disorder, Chest discomfort, Eating disorder, Aphasia, Muscular weakness, Cataract, Dysarthria, Sneezing, Confusional state, Carotid artery thrombosis, Gangrene, Anxiety, Pyrexia, Respiratory tract congestion, Rhinorrhoea, Dysphagia, Nasopharyngitis, Hemiplegia, Hemiparesis, Sinus congestion, Cerebrovascular accident, Vomiting, Rheumatoid arthritis, Cough, Skin exfoliation, Malaise, Influenza like illness, Fatigue, Sinusitis, Coordination abnormal, Gastrointestinal disorder, Arthritis, Sensory loss, Affect lability, Muscle spasticity, Psoriasis, Nausea, Cystitis, Angina pectoris, Maternal exposure during pregnancy, Neurologic neglect syndrome, Palpitations, Personality disorder, Asthenia, Blood pressure increased, Pneumonia, Sinus disorder, Headache, Motor dysfunction, Fall, Pain, Influenza, Arterial occlusive disease, Skin haemorrhage, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ROSUVASTATIN CALCIUM, INSULIN GLARGINE, ALISKIREN HEMIFUMARATE, ALISKIREN HEMIFUMARATE, ALISKIREN HEMIFUMARATE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, HYDROCHLOROTHIAZIDE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DULOXETINE HYDROCHLORIDE, LISINOPRIL, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, RAMIPRIL, PREDNISONE, RITUXIMAB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, TELMISARTAN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, MORPHINE SULFATE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, ATORVASTATIN CALCIUM, CALCIUM CARBONATE, BISOPROLOL FUMARATE, INSULIN LISPRO, CANDESARTAN CILEXETIL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACITRETIN, PROCHLORPERAZINE, LEVOTHYROXINE, METHYLPREDNISOLONE ACETATE, LEVOTHYROXINE SODIUM, CANDESARTAN, DIMENHYDRINATE, DIMENHYDRINATE, INSULIN DETEMIR, IRBESARTAN, IRBESARTAN, IRBESARTAN, PREGABALIN, ERGOCALCIFEROL, CYANOCOBALAMIN, IRBESARTAN, ONDANSETRON HYDROCHLORIDE, SITAGLIPTIN, ZOLPIDEM TARTRATE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, COAL TAR, USTEKINUMAB, EZETIMIBE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, |
||||
| 151 | 25130323 |
US |
2 | |
Maternal exposure during pregnancy, |
||||
BEMPEDOIC ACID AND EZETIMIBE, |
||||
| 152 | 25130608 |
US |
24 | 2 |
Maternal exposure during pregnancy, |
||||
DUPILUMAB, |
||||
| 153 | 25130819 |
US |
2 | |
Abortion spontaneous, Maternal exposure during pregnancy, Product dose omission issue, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 154 | 25130941 |
US |
26 | 2 |
Maternal exposure during pregnancy, |
||||
SAPROPTERIN DIHYDROCHLORIDE, |
||||
| 155 | 25131108 |
CZ |
2 | |
Abortion spontaneous, Maternal exposure during pregnancy, |
||||
OFATUMUMAB, |
||||
| 156 | 25131461 |
CA |
2 | |
Abortion spontaneous, Maternal exposure during pregnancy, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, |
||||
| 157 | 25131507 |
US |
2 | |
Maternal exposure during pregnancy, Drug ineffective, Pregnancy on contraceptive, |
||||
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL AND FERROUS FUMARATE, |
||||
| 158 | 25131610 |
US |
33 | 2 |
Thyroid disorder, Maternal exposure during pregnancy, Maternal exposure during breast feeding, Gestational diabetes, Incorrect dose administered, Nausea, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 159 | 25131936 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 160 | 25131939 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 161 | 25121246 |
FR |
30 | 2 |
Drug abuse, Premature separation of placenta, Maternal exposure during pregnancy, Toxicity to various agents, |
||||
ALPRAZOLAM, MIRTAZAPINE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ZOLPIDEM TARTRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 162 | 25121387 |
CA |
21 | 2 |
Toxicity to various agents, Unresponsive to stimuli, Maternal exposure during pregnancy, |
||||
OLANZAPINE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, SERTRALINE, FENTANYL, AMPHETAMINE, |
||||
| 163 | 25121441 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 164 | 25121465 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 165 | 25121470 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 166 | 25121502 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 167 | 25121523 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 168 | 25121539 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 169 | 25121718 |
FR |
41 | 2 |
Hepatic cirrhosis, Portal hypertension, Condition aggravated, Maternal exposure during pregnancy, |
||||
TENOFOVIR DISOPROXIL FUMARATE, ENTECAVIR, |
||||
| 170 | 25121925 |
IN |
26 | 2 |
Premature delivery, Eclampsia, Caesarean section, Off label use, Maternal exposure during pregnancy, |
||||
LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, LABETALOL, |
||||
| 171 | 25121943 |
US |
2 | |
Maternal exposure during pregnancy, |
||||
INSULIN LISPRO, |
||||
| 172 | 25121967 |
US |
24 | 2 |
Maternal exposure during pregnancy, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, METHIMAZOLE, PROPYLTHIOURACIL, METOPROLOL TARTRATE, METOPROLOL, AMOXICILLIN AND CLAVULANATE POTASSIUM, |
||||
| 173 | 25122177 |
GB |
2 | |
Abortion spontaneous, Maternal exposure during pregnancy, |
||||
OFATUMUMAB, |
||||
| 174 | 25122257 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 175 | 25122270 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 176 | 25122281 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 177 | 25122298 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 178 | 25122314 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 179 | 25122370 |
US |
2 | |
Amniotic cavity infection, Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 180 | 25122471 |
FR |
||
Abortion spontaneous, Maternal exposure before pregnancy, Maternal exposure during pregnancy, |
||||
PREGABALIN, SERTRALINE, |
||||
| 181 | 25122722 |
CA |
50 | 2 |
Systemic lupus erythematosus, Exposure during pregnancy, Abdominal discomfort, Contusion, Adverse drug reaction, Fibromyalgia, Gait inability, Fatigue, Facet joint syndrome, Dyspnoea, Asthenia, Autoimmune disorder, Folliculitis, Drug intolerance, Asthma, Bursitis, Diarrhoea, Arthropathy, Blood cholesterol increased, Dry mouth, Duodenal ulcer perforation, Anxiety, Dizziness, Contraindicated product administered, Chest pain, Deep vein thrombosis postoperative, Condition aggravated, Arthralgia, C-reactive protein abnormal, Confusional state, Abdominal pain, Abdominal pain upper, Malaise, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Nasopharyngitis, Night sweats, Obesity, Oedema, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pruritus, Psoriatic arthropathy, Pyrexia, Rash, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Wound, Sciatica, Sinusitis, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Synovitis, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Gastrointestinal disorder, Hypertension, Discomfort, Impaired healing, Lower respiratory tract infection, Alopecia, Hypersensitivity, Lip dry, C-reactive protein, Lower limb fracture, Anti-cyclic citrullinated peptide antibody positive, Blister, Migraine, Infection, Helicobacter infection, Swollen joint count increased, Decreased appetite, Drug hypersensitivity, General physical health deterioration, Glossodynia, Hand deformity, Headache, Hepatic enzyme increased, Hypoaesthesia, Inflammation, Infusion related reaction, Injury, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Liver disorder, Liver injury, Lung disorder, Red blood cell sedimentation rate increased, Hepatic cirrhosis, Colitis ulcerative, Crohn^s disease, Feeling hot, Ill-defined disorder, Insomnia, Intentional product use issue, Drug ineffective, Off label use, Product use in unapproved indication, Product use issue, Rectal haemorrhage, Retinitis, Therapy non-responder, Oedema, Pyrexia, Medication error, Nausea, Pregnancy, Prescribed overdose, Therapeutic product effect decreased, Treatment failure, Upper respiratory tract infection, Maternal exposure timing unspecified, Oedema peripheral, Sleep disorder, Sleep disorder due to general medical condition, hypersomnia type, Hip arthroplasty, Knee arthroplasty, Maternal exposure during pregnancy, |
||||
IBUPROFEN, DICLOFENAC, DICLOFENAC SODIUM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, INFLIXIMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, PREGABALIN, METHYLPREDNISOLONE SODIUM SUCCINATE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DESOXIMETASONE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, CELECOXIB, CELECOXIB, CELECOXIB, CETRIMIDE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, IBUPROFEN, IBUPROFEN, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREGABALIN, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ADALIMUMAB, ADALIMUMAB, HYALURONIDASE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, APREMILAST, APREMILAST, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, ACETAMINOPHEN AND DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN AND PHENYLEPRINE HCL, ACETAMINOPHEN AND DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN AND PHENYLEPRINE HCL, ACETAMINOPHEN AND DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN AND PHENYLEPRINE HCL, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, ASCORBIC ACID, ASCORBIC ACID, ASCORBIC ACID, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, HYDROXYCHLOROQUINE SULFATE, DEXTROMETHORPHAN HYDROBROMIDE, HYDROCORTISONE BUTYRATE, CALCIUM GLUCONATE, GOLIMUMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, SULFAMETHOXAZOLE AND TRIMETHOPRIM, TOCILIZUMAB, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, |
||||
| 182 | 25122802 |
JP |
31 | 2 |
Maternal exposure during pregnancy, Postpartum haemorrhage, Presyncope, |
||||
SATRALIZUMAB, SATRALIZUMAB, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, |
||||
| 183 | 25122915 |
FR |
0 | 1 |
Premature baby, Low birth weight baby, Maternal exposure during pregnancy, |
||||
APIXABAN, FUROSEMIDE, FUROSEMIDE, ENOXAPARIN SODIUM, ENOXAPARIN SODIUM, SPIRONOLACTONE, DAPAGLIFLOZIN, SACUBITRIL AND VALSARTAN, BISOPROLOL FUMARATE, |
||||
| 184 | 25123019 |
FR |
2 | |
Microcephaly, Maternal exposure during pregnancy, Foetal growth restriction, Foetal heart rate disorder, Term birth, Low birth weight baby, Transposition of the great vessels, |
||||
BISOPROLOL FUMARATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LEVOTHYROXINE, |
||||
| 185 | 25123169 |
US |
35 | 2 |
Paraesthesia, Maternal exposure during pregnancy, |
||||
IRON SUCROSE, IRON SUCROSE, |
||||
| 186 | 25123656 |
ES |
29 | 2 |
Seizure, Drug ineffective, Maternal exposure during pregnancy, |
||||
LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, CLOBAZAM, LEVOTHYROXINE, FOLIC ACID, FOLIC ACID, |
||||
| 187 | 25123690 |
FR |
||
Meningocele, Maternal exposure during pregnancy, |
||||
SERTRALINE, QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 188 | 25123976 |
US |
2 | |
Maternal exposure during pregnancy, Psoriasis, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 189 | 25124154 |
CA |
43 | 2 |
Lung disorder, Drug hypersensitivity, Infusion related reaction, Infusion site reaction, Injury, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver function test increased, Memory impairment, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal pain, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Onychomadesis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Peripheral swelling, Peripheral venous disease, Rash, Sleep disorder, Swelling, Synovitis, Taste disorder, Vomiting, Weight increased, Wound, Drug intolerance, Drug ineffective, Intentional product use issue, Contraindicated product administered, Maternal exposure during pregnancy, Product quality issue, Product use in unapproved indication, Product use issue, Therapeutic product effect decreased, Therapeutic product effect incomplete, Treatment failure, |
||||
MIRABEGRON, CELECOXIB, CELECOXIB, SECUKINUMAB, ERGOCALCIFEROL, INFLIXIMAB, LEFLUNOMIDE, LEVOMILNACIPRAN, MAGNESIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, NAPROXEN, NAPROXEN SODIUM, MEPOLIZUMAB, ABATACEPT, APREMILAST, OXYCODONE, PANTOPRAZOLE, PHENYLEPHRINE HYDROCHLORIDE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RAMIPRIL, RANITIDINE HYDROCHLORIDE, GOLIMUMAB, TOPIRAMATE, TOPIRAMATE SPINKLE, TRETINOIN, VITAMIN C, TOFACITINIB, |
||||
| 190 | 25124699 |
US |
2 | |
Postpartum haemorrhage, Maternal exposure during pregnancy, Therapeutic product effect decreased, |
||||
OXYTOCIN, |
||||
| 191 | 25124877 |
DE |
33 | 2 |
Abortion spontaneous, Maternal exposure during pregnancy, |
||||
OFATUMUMAB, |
||||
| 192 | 25124916 |
DE |
2 | |
Foetal malposition, Maternal exposure during pregnancy, |
||||
NATALIZUMAB, NATALIZUMAB, NATALIZUMAB, |
||||
| 193 | 25125163 |
JP |
37 | 2 |
Maternal exposure during pregnancy, Premature labour, Gestational hypertension, Renal impairment, Premature delivery, |
||||
RITUXIMAB, ROMIPLOSTIM, |
||||
| 194 | 25125408 |
US |
2 | |
Rheumatoid arthritis, Illness, Maternal exposure before pregnancy, Maternal exposure during pregnancy, Maternal exposure during breast feeding, Intentional dose omission, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 195 | 25125669 |
US |
2 | |
Maternal exposure during pregnancy, |
||||
DUPILUMAB, |
||||
| 196 | 25125793 |
FR |
44 | 2 |
Abortion spontaneous, Maternal exposure before pregnancy, Maternal exposure during pregnancy, |
||||
PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, SERTRALINE, SERTRALINE, SERTRALINE, SERTRALINE, |
||||
| 197 | 25126038 |
IL |
2 | |
Foetal heart rate decreased, Umbilical cord abnormality, Maternal exposure during pregnancy, |
||||
PEGINTERFERON BETA-1A, |
||||
| 198 | 25126044 |
BR |
32 | 2 |
Caesarean section, Maternal exposure during pregnancy, Premature labour, Premature delivery, |
||||
NATALIZUMAB, NATALIZUMAB, |
||||
| 199 | 25126065 |
SE |
20 | 2 |
Drug ineffective, Pregnancy with implant contraceptive, Maternal exposure during pregnancy, |
||||
ETONOGESTREL, |
||||
| 200 | 25115726 |
ES |
33 | 2 |
Orbital oedema, Off label use, Maternal exposure during pregnancy, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28